Mai Jing Liao
Corporate Officer/Principal bei Hbm Suzhou Co. Ltd.
Profil
Mai Jing Liao is the founder of HBM Holdings Ltd., which was founded in 2016.
He held the position of Executive Director & Chief Business Officer from 2018 to 2021.
Currently, he is the Chief Business Officer at Hbm Suzhou Co. Ltd.
Dr. Liao's former positions include Associate Director-Strategic Marketing at Johnson & Johnson from 2013 to 2016 and Chief Business Officer at Harbour BioMed (Shanghai) Co., Ltd.
His education includes an MBA from Johnson Graduate School of Management in 2007 and a doctorate from the University of North Carolina System in 1999.
Aktive Positionen von Mai Jing Liao
| Unternehmen | Position | Beginn |
|---|---|---|
| Hbm Suzhou Co. Ltd. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mai Jing Liao
| Unternehmen | Position | Ende |
|---|---|---|
| HBM HOLDINGS LIMITED | Gründer | 17.09.2021 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.06.2016 |
Harbour BioMed (Shanghai) Co., Ltd.
 Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Corporate Officer/Principal | - |
Ausbildung von Mai Jing Liao
| University of North Carolina System | Doctorate Degree |
| Johnson Graduate School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HBM HOLDINGS LIMITED | Health Technology |
| JOHNSON & JOHNSON | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Hbm Suzhou Co. Ltd. | |
Harbour BioMed (Shanghai) Co., Ltd.
Harbour BioMed (Shanghai) Co., Ltd. BiotechnologyHealth Technology Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China. | Health Technology |
